About: Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1996 (uk) im Mai 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1996 (ast) scientific article published on 01 May 1996 (en)
publication date	wds:Q71338485-D7814BAF-A173-4F17-AF4E-DBCF22D215D5
publication date	1996-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71338485-EE7C0725-FB01-4500-9561-4BD22A60967B
language of work or name	English
author name string	wds:Q71338485-708A3D69-469F-4768-830B-8D4059C0EAE2 wds:Q71338485-87090FA6-1720-49D3-B8BE-AC40AE13E9E0
author name string	P Gehanno P Berche
rdfs:label	Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group (en) Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group (nl)
skos:prefLabel	Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group (en) Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group (nl)
name	Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group (en) Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group (nl)
title	wds:Q71338485-D6A90A67-41A5-42FB-B2CF-98CA39F55074
title	Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group (en)
page(s)	wds:Q71338485-E5127E66-D85A-4C0E-AFA2-B53585569F60
page(s)	105-114
instance of	wds:Q71338485-81C30235-4DFB-40CA-BABC-F0C92AB7BF1C
instance of	scholarly article
PubMed ID	wds:Q71338485-212EBE61-BBE9-4D28-B813-39F0D8336E17
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8737130
PubMed ID	8737130
published in	wds:Q71338485-81B8BCAD-C5B0-46F0-9A3B-FF5BECF13F00
published in	Journal of Antimicrobial Chemotherapy
volume	wds:Q71338485-EAB54489-76D3-4C87-BE78-64077FA4C26C
volume	37 Suppl A
DOI	wds:Q71338485-4DD629D9-414C-489B-A8D8-3D2F613F78DC
DOI	http://dx.doi.org/10.1093/JAC/37.SUPPL_A.105
DOI	10.1093/JAC/37.SUPPL_A.105
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71338485
is cites work of	Antibiotics for acute maxillary sinusitis in adults Antibiotics for acute maxillary sinusitis Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin. Antibiotics for acute maxillary sinusitis Levofloxacin and sparfloxacin: new quinolone antibiotics In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis. Potential interactions of the extended-spectrum fluoroquinolones with the CNS. Cefuroxime axetil: an updated review of its use in the management of bacterial infections Antibiotics for acute maxillary sinusitis in adults Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group. Moxifloxacin in the Treatment of Acute Maxillary Sinusitis after First-Line Treatment Failure and Acute Sinusitis with High Risk of Complications The Role of Quinolones in Upper Respiratory Tract Infections Economic evaluation of antibacterials in the treatment of acute sinusitis Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus puncture Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials [Role of new fluoroquinolones in respiratory infections in primary care]
is cites work of	wds:Q54137490-7304F1C6-F2A7-4964-B18E-FA8631E5AFB2 wds:Q73952989-407A5DB8-A525-4EC0-8BC1-191EFC3CD0DA wds:Q34370476-C857F2B4-0428-4A56-8E90-CBB2E76C011B wds:Q24248717-BB5E3920-4460-41F6-B986-14178536BA0A wds:Q74079698-A11D2E88-D915-448A-884E-B131A3DA8044 wds:Q24653970-C4932D51-10CB-4ACC-9CAB-28927AC7DF4D wds:Q24200440-EF66530E-4081-4217-A14D-15A680A66E12 wds:Q44637928-1F4AF5F8-428D-4861-8610-D01B66BE038C wds:Q54152283-972AE0F8-CB96-4686-B254-1A199A751DF3 wds:Q33241517-5BBDF464-E356-43FD-88E7-A0DBDAC331C2 wds:Q24242923-02F737AF-F106-4175-AAF2-340E631C4ABC wds:Q54152289-471C32CB-D4F1-4678-BD12-059DC30BEA8E wds:Q24186686-360FBCF1-79BE-49CE-8A95-2AD3B117DCE0 wds:Q33717059-A32CC2BF-0DF8-4446-804C-8ED6237AEF5F wds:Q37881273-0F116F21-2703-4C32-8D6E-96149E157428 wds:Q43518855-2AE57B39-4E9B-4FFF-BF89-B00C6D85A514 wds:Q44854980-7B4AEF0C-4D4D-49FE-8B95-8A3717F54F42 wds:Q77801720-3D3F13FE-B889-4DAA-BE34-9A4DA171825F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 168 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software